US House committee moves quickly to approve bill limiting business with Chinese biotech firms
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
The bill would prevent federal agencies from contracting with five Chinese biotech companies – BGI Group, MGI, Complete Genomics, Wuxi AppTec, and Wuxi Biologics.